Global Ultrasonic Soft Tissue Cutting and Hemostasis Equipment Market Growth 2024-2030

Global Ultrasonic Soft Tissue Cutting and Hemostasis Equipment Market Growth 2024-2030

The working principle of the ultrasonic cutting hemostatic knife is to convert electrical energy into mechanical energy through the transducer, and the ultrasonic system in the handle amplifies the kinetic energy on the knife shaft to cut tissue. After the tissue in contact with the cutter head absorbs ultrasonic energy, the protein hydrogen bonds are broken, and then coagulated and denatured. At the same time, the moisture in the tissue is vaporized, which further helps the tissue stratification.

The global Ultrasonic Soft Tissue Cutting and Hemostasis Equipment market size is projected to grow from US$ 719 million in 2023 to US$ 1112.3 million in 2030; it is expected to grow at a CAGR of 6.4% from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Ultrasonic Soft Tissue Cutting and Hemostasis Equipment Industry Forecast” looks at past sales and reviews total world Ultrasonic Soft Tissue Cutting and Hemostasis Equipment sales in 2023, providing a comprehensive analysis by region and market sector of projected Ultrasonic Soft Tissue Cutting and Hemostasis Equipment sales for 2024 through 2030. With Ultrasonic Soft Tissue Cutting and Hemostasis Equipment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Ultrasonic Soft Tissue Cutting and Hemostasis Equipment industry.

This Insight Report provides a comprehensive analysis of the global Ultrasonic Soft Tissue Cutting and Hemostasis Equipment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Ultrasonic Soft Tissue Cutting and Hemostasis Equipment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Ultrasonic Soft Tissue Cutting and Hemostasis Equipment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Ultrasonic Soft Tissue Cutting and Hemostasis Equipment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Ultrasonic Soft Tissue Cutting and Hemostasis Equipment.

The global medical device market is estimated to be US$603.3 billion in 2023, with a compound annual growth rate of 5% expected in the next six years. Global health care expenditure currently accounts for approximately 10% of global GDP, and the proportion will continue to increase in the next few years. This is primarily due to the increasing demand for healthcare from an aging population, the rising prevalence of chronic and infectious diseases, and the expansion of emerging markets. The medical device market plays an important role in the healthcare spending industry. The medical device market is driven by a variety of factors, including increasing global demand for advanced medical services, advancements in medical technology, growing geriatric population, increasing medical expenditures, and increasing awareness of early stage disease diagnosis and treatment.

This report presents a comprehensive overview, market shares, and growth opportunities of Ultrasonic Soft Tissue Cutting and Hemostasis Equipment market by product type, application, key manufacturers and key regions and countries.

Segmentation by type
Disposable
Reusable

Segmentation by application
Hospitals
Ambulatory Surgical Centers
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Ethicon
Johnson & Johnson
Misonix Inc.
Sonacare Medical
Integra LifeSciences
Alpinion Medical Systems.
New Surgical Instruments Co.
Olympus America
Soring GmbH
Medtronic
Sword Medical
Roboz Surgical Instrument Co.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Ultrasonic Soft Tissue Cutting and Hemostasis Equipment market?

What factors are driving Ultrasonic Soft Tissue Cutting and Hemostasis Equipment market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Ultrasonic Soft Tissue Cutting and Hemostasis Equipment market opportunities vary by end market size?

How does Ultrasonic Soft Tissue Cutting and Hemostasis Equipment break out type, application?

Please note: The report will take approximately 2 business days to prepare and deliver.